336 related articles for article (PubMed ID: 30049187)
1. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Pereira KM; Feitosa SG; Lima AT; Luna EC; Cavalcante RB; de Lima KC; Chaves FN; Costa FW
Asian Pac J Cancer Prev; 2016; 17(1):147-51. PubMed ID: 26838200
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
4. A correlation of immunohistochemical expression of
Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
[TBL] [Abstract][Full Text] [Related]
5. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
6. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis.
Martins F; de Sousa SC; Dos Santos E; Woo SB; Gallottini M
J Oral Pathol Med; 2016 Nov; 45(10):746-752. PubMed ID: 26991907
[TBL] [Abstract][Full Text] [Related]
7. Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients.
Wiphakphongpakorn P; Juengsomjit R; Poomsawat S; Meesakul O; Bhattarai BP; Klongnoi B; Buajeeb W; Khovidhunkit SP
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1257-1264. PubMed ID: 38679985
[TBL] [Abstract][Full Text] [Related]
8. Stathmin! An immunohistochemical analysis of the novel marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia.
Vadla P; Yeluri S; Deepthi G; Guttikonda VR; Taneeru S; Naramala S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3317-3323. PubMed ID: 33247690
[TBL] [Abstract][Full Text] [Related]
9. Expression of CDK6 in Oral Squamous Cell Carcinomas.
Andisheh-Tadbir A; Ashraf MJ; Jeiroodi N
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1013-1016. PubMed ID: 29693970
[TBL] [Abstract][Full Text] [Related]
10. GLUT-1 immunoexpression in oral epithelial dysplasia, oral squamous cell carcinoma, and verrucous carcinoma.
Angadi VC; Angadi PV
J Oral Sci; 2015 Jun; 57(2):115-22. PubMed ID: 26062860
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Rao RS; Raju K L; Augustine D; Patil S
Cancer Control; 2020; 27(1):1073274820904959. PubMed ID: 32951453
[TBL] [Abstract][Full Text] [Related]
12. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
Sumita Y; Yamazaki M; Maruyama S; Abé T; Cheng J; Takagi R; Tanuma JI
Oncol Rep; 2018 Nov; 40(5):2487-2496. PubMed ID: 30132562
[TBL] [Abstract][Full Text] [Related]
14. MutSα and MutLα immunoexpression analysis in diagnostic grading of oral epithelial dysplasia and squamous cell carcinoma.
Jessri M; Dalley AJ; Farah CS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):74-82. PubMed ID: 25446502
[TBL] [Abstract][Full Text] [Related]
15. Biological significance of 5-hydroxymethylcytosine in oral epithelial dysplasia and oral squamous cell carcinoma.
Cuevas-Nunez MC; Gomes CBF; Woo SB; Ramsey MR; Chen XL; Xu S; Xu T; Zhan Q; Murphy GF; Lian CG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jan; 125(1):59-73.e2. PubMed ID: 28743666
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
17. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
Upadhyay J; Rao NN; Upadhyay RB
J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
[TBL] [Abstract][Full Text] [Related]
19. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T
Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914
[TBL] [Abstract][Full Text] [Related]
20. Joint detection of claudin-1 and junctional adhesion molecule-A as a therapeutic target in oral epithelial dysplasia and oral squamous cell carcinoma.
Upadhaya P; Barhoi D; Giri A; Bhattacharjee A; Giri S
J Cell Biochem; 2019 Oct; 120(10):18117-18127. PubMed ID: 31161679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
